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Cardiovascular Research
and the Laboratory Mouse
A Jackson Laboratory Resource Manual

This resource manual highlights the importance of cardiovascular
research and the extensive resources available for researchers at
The Jackson Laboratory.
It briefly describes the following:
• Over 30 JAX® Mice cardiovascular research models
• Summaries of recent mouse-based cardiovascular research
• Comparisons of cardiovascular phenotypes among the
Mouse Phenome Project strains
• Resources available through our Center for New Models of
Heart, Lung, Blood, and Sleep Disorders
• Courses, online resources and JAX® Services suitable for
		 cardiovascular research

Cover Photos
Front cover, left: Fatty acid plaque in mouse aortic valve. Courtesy of
Karen Svenson.
Front cover, middle: The C57BL/6-Tg(APOA1)1Rub/J (001927)
strain has a reduced susceptibility to diet-induced atherosclerosis.
Front cover, right: Fatty acid plaque in mouse aorta. Courtesy of
Karen Svenson.
Back cover: B6.129P2-Apoetm1Unc/J (002052) Apoe-deficient mice
are one of the most relevant models for atherosclerosis research.
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Cardiovascular Research
and the Laboratory Mouse
According to the Centers for Disease Control (CDC:
www.cdc.gov/heartdisease/facts), heart disease and stroke
are the first and third leading causes of death for both men
and women in the United States, accounting for nearly 40%
of all deaths annually. More than 70 million Americans have
some kind of cardiovascular disease. Coronary heart disease
is a leading cause of premature, permanent disability in the
U.S. workforce. In 2006, the projected cost of heart disease in
the U.S. was 256 billion dollars.
Two of the major independent risk factors for
cardiovascular diseases are high blood pressure and high
blood cholesterol. Other important risk factors include
diabetes, tobacco use, physical inactivity, poor nutrition, and
obesity. About 30% of U.S. adults have high blood pressure,
and 25% have high cholesterol levels. A 12- to 13-point

reduction in blood pressure could reduce heart attacks by
21%, strokes by 37%, and all deaths from cardiovascular
disease by 25%. A 10% decrease in total blood cholesterol
levels could reduce the incidence of coronary heart disease
by as much as 30% (CDC: www.cdc.gov/heartdisease/facts).
Although a great deal of cardiovascular research
has already been conducted, much more is needed. Our
resources, especially our JAX® Mice models and
JAX® Services, will undoubtedly play an important role in
that research. This Resource Manual briefly describes the
role of the laboratory mouse in cardiovascular research,
selected JAX® Mice models, JAX® Services, online resources
applicable to cardiovascular research, and ongoing
cardiovascular research conducted by our scientists.

The Jackson Laboratory
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Cardiovascular Research and the Laboratory Mouse
Atherosclerosis
Atherosclerosis, also called coronary heart disease (CHD),
is essentially a chronic inflammatory reaction to modified
lipoproteins, primarily oxidized low density lipoprotein
(LDL). It is one of the most devastating of human diseases
and a leading cause of death in industrialized countries
(Kreger et al. 1994; Beckman et al. 2002). Older women
and women who begin hormone therapy over 10 years
after menopause are at increased risk of developing
atherosclerosis (Rossouw et al. 2007). Atherosclerosis is
particularly hard to fight because it is influenced by so many
genetic and environmental factors, especially diet (Gylling
and Miettinen 2001; Cohn 2002).
The laboratory mouse has played a crucial role in
atherosclerosis research and will likely continue to do so
(Paigen 1995; Rader and Pure 2000; Glass and Witztum
2001; Daugherty 2002; Fazio and Linton 2002; Allayee
et al. 2004; Wang et al. 2005a). At least 21 atherosclerosis
quantitative trait loci (QTLs) have been identified in the
mouse (Wang et al. 2005a): seven in high-fat diet models
only, nine in sensitized models (apolipoprotein E- or low
density lipoprotein receptor-deficient mice) only, and five
in both models.
More than half of the mouse and human atherosclerosis
QTLs are likely concordant, having the same underlying
genes (Stoll et al. 2000; Sugiyama et al. 2001; Wang et al.
2005a). More mouse QTLs concordant with human QTLs
could possibly be found 1) if additional crosses using

previously unused parental strains were performed (11 of
the 13 crosses performed so far used B6 mice as one of the
parents), 2) if, in addition to lesion size, characterization
of the atherosclerosis phenotype in the mouse would
incorporate plaque stability (as is done in humans), 3)
through mutagenesis screens, and 4) by using new genomic
and bioinformatics tools (Wang et al. 2005a). Performing
additional crosses (with atherosclerosis susceptible strains
such as SM/J and SWR/J) would not only reveal new
atherosclerosis QTLs but would verify previous QTLs,
providing the information necessary to identify QTL genes
(Wang and Paigen 2005; Wang
et al. 2004).
The genes underlying both human and mouse
atherosclerosis QTLs are largely unknown. Of over
80 mouse and at least 17 human genes known to influence
atherosclerosis, only about a quarter fall into human
atherosclerosis QTLs (Wang et al. 2005a). Only two of the
genes underlying the 21 mouse atherosclerosis QTLs have
been identified, and half of the human atherosclerosis
QTLs have no obvious candidate genes (Wang et al. 2005a).
Because of concordance, discovering these genes in the
mouse first will be much more cost-effective, less time
consuming, and less fraught with ethical issues than would
finding them in humans first, especially now that many new
genetic, genomic, and bioinformatics tools for the mouse
are available.

A map showing the location of mouse atherosclerosis QTLs
(and their candidate genes) is available from The Jackson Laboratory’s
Mouse Heart, Lung, Blood and Sleep Disorders Center (HLBS) website at this URL:
pga.jax.org/qtl/index
The map is linked to resource tables that include chromosome locations,
mouse crosses, statistical significances, and references for each QTL.
A map of human atherosclerosis QTLs (at least 27 have been reported)
is available from the same website.
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Lipid Homeostasis
Given the compelling evidence that HDL protects against
atherosclerosis (Brewer 2004; Gotto and Brinton 2004),
human atherosclerosis-regulating genes might also be
identified by finding the genes underlying mouse HDL QTLs
and determining if their orthologs regulate HDL levels and
atherosclerosis susceptibility in humans. Many QTLs have
been found that regulate plasma levels of HDL cholesterol
(37 in mice, 30 in humans), low density lipoprotein (LDL)
cholesterol (25 in mice, 20 in humans) and triglycerides
(19 in mice, 30 in humans). Ninety-three percent, 100%,
and 80% of the human QTLs for HDL cholesterol, LDL
cholesterol, and triglycerides respectively have concordant
mouse QTLs, suggesting they have the same underlying
genes (Wang and Paigen 2005a; Wang and Paigen 2005b).

Identifying these genes should be facilitated considerably
by analyzing haplotypes (DiPetrillo et al. 2005; Wang et al.
2004), data combined from multiple crosses (Wittenburg et
al. 2006; DiPetrillo et al. 2005), and by using the mouse-tohuman-to-mouse paradigm (Wang and Paigen 2005b).
Maps of HDL, LDL, and triglyceride QTLs (and candidate
genes) found in the mouse can be accessed from the HLBS
website: pga.jax.org/qtl/index. Each map is linked to
resource tables that include chromosome locations, mouse
crosses, statistical significances, and references for each QTL.
Maps of human QTLs for the same phenotypes are accessible
from the same site.

Blood Pressure
Hypertension

Human hypertension greatly increases the risk of
coronary heart disease, congestive heart failure, stroke,
and kidney disease. Additionally, it is often associated with
and complicated by obesity, dyslipidemia, and non-insulin
dependent diabetes mellitus (NIDDM) (Bonora et al. 1998).
More than 50 million Americans suffer from hypertension,
and 12.7 million of them alleviate its symptoms by taking
medicinal drugs (Smith 2000). The alleles associated with
essential hypertension in humans have been difficult to
find because the genetic backgrounds and environmental
influences in human populations are almost impossible to
control. These have been much easier to control in inbred
rodent populations.

Preeclampsia

Preeclampsia is a disorder that occurs only during
pregnancy and the postpartum period and affects both the
mother and the unborn baby. Occuring in at least five to
eight percent of all pregnancies, preeclampsia is a rapidly
progressive condition characterized by high blood pressure
and protein in the urine. Although symptoms may include

swelling, sudden weight gain, headaches, and changes in
vision, some women with rapidly advancing disease report
few symptoms.
Typically, preeclampsia occurs after 20 weeks gestation,
but it can occur earlier. To diagnose and manage it,
proper prenatal care is essential. Preeclampsia and other
hypertensive disorders of pregnancy are a leading global
cause of maternal and infant illness and death, accounting
for at least 76,000 deaths yearly (The Preeclampsia
Foundation, www.preeclampsia.org).

The Emergence of the Mouse as a Blood
Pressure Model

Until recently, the rodent model most widely used to
study hypertension was the laboratory rat. With the advent
of genetic engineering and the development of equipment
capable of measuring blood pressure in small organisms,
the mouse has assumed an increasingly important role as
a model in blood pressure studies (Sugiyama et al. 2001a,
2001b, 2002; DiPetrillo et al. 2004; Tsukahara et al. 2004).

The Jackson Laboratory
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Cardiovascular Research at The Jackson Laboratory
Professor Beverly Paigen, Ph.D.

www.jax.org/research/faculty/beverly_paigen
Professor Paigen and her laboratory research the genetic
and environmental factors associated with atherosclerosis,
hypertension, high density lipoprotein (HDL)-cholesterol
levels, and cholesterol gallstone formation. Her staff and
colleagues Professor Gary Churchill and Research Associate
Renhua Li are pioneers in developing the technology and
statistical tools for mapping quantitative trait loci (QTLs)
and identifying underlying alleles associated with these
diseases. In the past 10 years, they have carried out over
25 QTL mouse crosses and have discovered over 250

disease-associated QTLs. Once they identify the diseasecausing alleles in the mouse, they and collaborators seek
to identify the orthologous alleles in humans. By using
a variety of comparative genetic approaches, they have
already identified one allele associated with susceptibility
to atherosclerosis and two associated with susceptibility to
hypertension in humans.
Professor Paigen and her colleagues have also contributed
a considerable amount of cardiovascular related data to the
Mouse Phenome Database.

Professor Beverly Paigen (center row, second from right) along with her research staff.
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Our Facilities
The Jackson Laboratory comprises two facilities: an East
Coast campus in Bar Harbor, Maine and a West Coast
campus in Sacramento, California. On both campuses
cardiovascular research, services and educational activities
take place.
The Jackson Laboratory repository on the Bar Harbor
campus is home to more than 4,000 strains of JAX® Mice
and growing daily. More than 1,200 of these strains are
maintained as live colonies and are available for distribution
to biomedical researchers worldwide. All of these strains,
including the live colonies, are cryopreserved to ensure they
continue to be available to the scientific community for
many years to come. This growing resource is the result of
the donation of hundreds of unique mouse models every
year by researchers around the world in an effort to preserve
today what may lead to the prevention and cure many
human diseases.

Bar Harbor, ME facility
• Primary production and distribution site for more than
4,000 genetically defined mouse strains

Sacramento, CA facility
• Site of JAX® In Vivo Services
• Production and distribution site for our most popular
JAX® Mice
• State-of-the-art phenotyping laboratory for
characterizing models, validating drug targets, and
testing drug efficacy
• Highly trained scientific staff, with experience
conducting in vivo studies in over 100 mouse models
• Comprehensive and integrated mouse breeding and
research services designed to provide efficient and costeffective solutions for mouse-based research
With nearly 80 years experience breeding and using mouse
models of disease, the quality of JAX® Mice & Services offered
at our facilities is unmatched. Our commitment drives our
mission: We discover the genetic basis for preventing, treating
and curing human diseases, and we enable research and
education for the global biomedical community.

• Research Staff of more than 200 Ph.D.s, M.D.s, and
D.V.M.s
• Center for the Mouse Tumor Biology Database (MTB),
Mouse Genome Informatics Database, and the Mouse
Phenome Database (MPD)
• World-renowned Courses and Conferences, and
training programs
• Model preconditioning and surgical services
• Revolutionary cryopreservation and recovery services
• Genetic research services (including gene mapping and
speed congenics)
• Microinjection services for new model development
• Comprehensive and integrated mouse breeding and
research services designed to provide efficient and
cost-effective solutions for mouse-based research

The Jackson Laboratory

5

JAX® Mice Models
Why Choose JAX® Mice
There are many reasons why you should choose JAX® Mice
for your cardiovascular research:

• The JAX® Mice Database (www.jax.org/jaxmice/query)
and the Mouse Genome Database (www.informatics.
jax.org) are renowned for their wealth of genotypic and
phenotypic information.

• JAX® Mice are the universally recognized gold standard
for genetically well-defined laboratory mice. Their
stable genotypes and phenotypes are the result of our
three-component Genetic Quality Control Program.
This program includes:

• JAX® Mice are the most widely published laboratory
mice. They have been referenced in more than 20,000
peer-reviewed publications. Over 90% of the published
references to B6 substrains cite our C57BL/6J strain.

1) Adherence to best practices in breeding and
colony management
2) The use of molecular test methods to confirm
genetic identity and genotypes
3) Phenotype monitoring
• JAX® Mice colonies are rigorously monitored for
both pathogenic and opportunistic agents. Our
comprehensive biosecurity program and state-of-the-art
facilities ensure the health quality of JAX® Mice.
• JAX® Mice are the most comprehensively characterized
laboratory mice as noted below:
1) The C57BL/6J strain (000664) is the only fully
sequenced mouse strain;
2) The National Institute of Environmental Health
Sciences (NIEHS) has resequenced 15 JAX® Mice
strains (SNP information available in the Mouse
Phenome Database, www.jax.org/phenome);
3) JAX® Mice were used to construct the most detailed
genetic map of any mammal except humans
(Shifman et al. 2006);
4) 40 genetically-diverse and widely-used JAX® Mice
strains are being comprehensively characterized
by the Mouse Phenome Project
(www.jax.org/phenome).
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• Over 4,000 JAX® Mice strains are available, including
inbred, hybrid, genetically engineered, recombinant
inbred, chromosome substitution, recombinant
congenic, and congenic strains.
• JAX® Mice are used for cardiovascular research in
medical schools, universities, and research centers all
over the world.
• Our Technical Information Support and Customer
Service teams leverage the expertise of our research staff
and mouse breeding experts to offer comprehensive and
integrated support to help you conduct your research
with JAX® Mice.
• JAX® Mice users have ready access to JAX® Services, a
comprehensive and highly customizable set of mouse
breeding and research services designed for the mousebased biomedical research community
(see JAX® Services section in this manual).

JAX® Mice Models
Importance of Genetic Background
You may occasionally see the following cautionary note in
JAX® Mice strain data sheets:
This strain is on a genetic background different from that
on which the allele was first characterized. It should be
noted that the phenotype could vary from that originally
described. We will modify the strain description if
necessary as published results become available.
We include this note because the technology for producing
genetically-engineered mice has been substantially refined,
resulting in an ever-increasing number, variety, and
availability of mutant mouse models. Similarly, the variety
of genetic backgrounds and the mutations characterized and
published on them are continually increasing. Generally,
alleles of interest (such as spontaneous mutations, targeted
mutations, transgenes, and congenic regions) are maintained

on one to several genetic backgrounds. One background
may be more vigorous, better characterized, more amenable
to scientific experiments, reproduce better, display a more
severe phenotype, or have some other advantages over
other backgrounds. However, these alleles are sometimes
transferred to backgrounds that are not well characterized.
Inattention to a mutant’s genetic background can seriously
confound research results. Each strain has unique
background alleles that may interact with and modify
the expression of a mutation, transgene, or other genetic
alteration. The likelihood of such modifier genes having a
confounding effect is especially high in an uncharacterized
background or in a segregating or mixed background of
unspecified origin. Even in a well-characterized strain,
undiscovered modifier genes may alter results, sometimes
making them unexplainable. Thus, before you decide which
mouse strain is appropriate for your research, consider its
genetic background.

The Mouse-to-Human-to-Mouse Paradigm
Professor Beverly Paigen of The Jackson Laboratory and other investigators have
successfully used the mouse-to-human-to-mouse paradigm to identify human
disease alleles. The process is as follows:
• Identify disease QTLs and the most promising candidate genes in the mouse.
• Determine if polymorphisms in the human orthologs of these candidate genes
are associated with the same disease in humans.
• Return to the mouse to obtain experimental proof that polymorphisms of the
gene can cause the disease.
The paradigm has been used successfully to establish the following
gene-disease relationships:
• TNFSF4 (encoding OX40 ligand) is significantly associated with myocardial
infarction and coronary artery disease in humans (Wang et al. 2005b);
• CTLA4 (encoding cytotoxic T-lymphocyte-associated protein 4) is
significantly associated with autoimmune disorders, including Graves disease,
autoimmune hypothyroidism, and type 1 diabetes (Ueda et al. 2003);
• POMC (encoding pro-opiomelanocortin-alpha [MIM 176830]) is significantly
associated with obesity (Krude et al. 1998; Hixson et al. 1999);
• EN2 (encoding engrailed 2 [MIM 131310]) is significantly associated with
autism-spectrum disorder (Gharani et al. 2004).
The Jackson Laboratory
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JAX® Mice Models
JAX® Mice Models
In the following pages, we describe over 30 of the most
commonly used and promising JAX® Mice models suitable
for cardiovascular research. The descriptions are abridged
from the JAX® Mice Database and scientific journals. For
more detailed information and/or comprehensive lists,
consult the following:
• JAX® Mice Database (www.jax.org/jaxmice):
The JAX® Mice Database is the most comprehensive
source of JAX® Mice strain information. Many of
the strains are described according to mammalian
phenotype terms. Strains for cardiovascular research
can be searched by research area.
• The Mouse Phenome Database
(MPD, www.jax.org/phenome): The MPD is the
database for the Mouse Phenome Project, a coordinated
international effort to establish a collection of baseline
phenotypic data for a set of commonly used and
genetically diverse inbred mouse strains.

8

The Jackson Laboratory

• The Center for New Mouse Models of Heart, Lung,
Blood, and Sleep Disorders (www.nhlbi.nih.gov/
resources/pga): The goal of the JAX® HLBS Center is to
provide the biomedical research community with new
information, tools, and resources for understanding
the genetic bases of atherosclerosis, hypertension, lung
function, blood formation, thrombosis, obesity, and
sleep function.
• The Cardiovascular Models Research Page
(www.jax.org/jaxmice/research/cardiovascular):
This downloadable pdf lists over 125 JAX® Mice
strains suitable for cardiovascular research. Strains are
categorized by research area (such as atherosclerosis,
hypertension, hypercholesteremia, etc.) and gene symbol.
• References: References are provided with each strain
description in this manual. Additional ones are available
from the strain data sheets in the JAX® Mice Database.

JAX® Mice Models

Atherosclerosis

Atherosclerosis
The Mouse Phenome Project Strains
Although many JAX® Mice strains have been used to
research atherosclerosis, they have been insufficient for
unraveling all the biochemical pathways involved (Wang
et al. 2005a). Until recently, choosing other strains was
difficult because atherosclerosis susceptibility and its
subphenotypes (such as cholesterol and triglyceride levels)
in most mouse strains were largely uncharacterized.
Professor Paigen of The Jackson Laboratory, her colleagues,
and other participants in the Mouse Phenome Project have
helped remedy that situation by extensively characterizing
these phenotypes for the Mouse Phenome Project strains
and submitting their data to the Mouse Phenome Database
(www.jax.org/phenome).

Atherosclerosis Susceptibility
and Infectious Agents

One of the environmental factors receiving considerable
attention as a risk factor for the development of chronic
inflammatory diseases, including Crohn’s disease, psoriasis,
type 2 diabetes, and atherosclerosis, is the aggravating
or precipitating influence of infectious agents (Karin et
al. 2006 Pellicano et al. 1999). In mice, infections with
cytomegalovirus, Chlamydia, or Porphyromonas gingivalis
have been found to increase the severity of atherosclerosis
(Vliegen et al. 2005, 2004, 2002; Chi et al. 2004; Burnett
et al. 2001; Hsich et al. 2001). Similarly, in her nearly 20
years of experience researching the genetic determinants
of atherosclerosis in mouse models, Dr. Paigen observed
that the degree to which mice develop atherosclerosis
seemed to depend on the presence of infectious agents in
the environment (pers. comm.). To test her hypothesis, she
and her colleagues examined the diet-induced susceptibility
to atherosclerosis in the Mouse Phenome Project strains in
barrier and non-barrier mouse rooms (Table 1) (Paigen et al.
2000a; 2000b). The barrier rooms were regularly monitored
for and maintained free of 15 viruses (mouse hepatitis
virus, two mouse parvoviruses, reovirus, Theiler’s mouse
encephalomyelitis virus, ectromelia virus, mouse rotavirus,

A map showing the location of atherosclerosis QTLs
identified in the mouse (and their candidate genes)
is available at pga.jax.org/qtl/index.

thymic virus, pneumonia virus of mice, Sendai virus, murine
cytomegalovirus, lactic dehydrogenase-elevating virus, K
virus, mouse adenovirus, and polyoma virus), 17 bacterial
species (including Helicobacter spp. and Pneumocystis
pneumotropica), two Mycoplasma species, external and
internal parasites, and Encephalitozoon cuniculi. Personnel
entering these rooms were required to wear caps, facemasks,
disposable gowns, shoe covers, and gloves. At the time, the
only known infectious agents in the non-barrier facilities
were Helicobacter sp, Pneumocystis, and Pasturella.
All mice were fed the same diet: however, whereas mice in
the barrier facilities were fed an atherogenic diet for
17 weeks, those in non-barrier facilities were fed the diet for
8 weeks.
Table 1 and the more detailed information in the
Mouse Phenome Database should help researchers find
more atherosclerosis QTLs, identify the underlying genes,
and determine how infectious agents influence susceptibility
to atherosclerosis.

The Jackson Laboratory
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Atherosclerosis

Table 1. Susceptibility to diet-induced atherosclerosis in Mouse Phenome Project strains housed in non-barrier and barrier
rooms.

Resistant

Males

Females

mean lesion size: 0 µm2

10

Intermediately Susceptible

Very Susceptible

mean lesion size: 1 to 499 µm2

mean lesion size: > 500 µm2

Non-barrier

Barrier

Non-barrier

Barrier

Non-barrier

Barrier

A/J, BALB/cJ,
BPH/2J, BPL/1J,
BUB/BnJ,
CAST/EiJ, CBA/J,
CE/J, CZECHII/EiJ,
FVB/NJ, KK/HlJ,
MOLF/EiJ,
NOD/ShiLtJ,
NON/ShiLtJ,
NZB/BlNJ,
NZW/LacJ,
PERA/EiJ, RIIIS/J,
SPRET/EiJ, WSB/EiJ

129S1/SvlmJ, A/J,
AKR/J, C3H/HeJ,
C57BL/10J, C57L/J,
CBA/J, CZECHI/EiJ,
DBA/2J, FVB/NJ,
JF1/Ms, KK/HlJ,
MSM/Ms,
NZW/LacJ,
PERA/EiJ, PL/J,
PWK/PhJ,
SEA/GnJ, SL/J,
SPRET/EiJ,

129S1/SvlmJ, AKR/J,
BPN/3J,
BTBR T+ tf/J,
C3H/HeJ,
C57BL/10J, DBA/1J,
DBA/2J, I/LnJ, LP/J,
P/J, PL/J, RBF/DnJ,
RF/J, SJL/J, SWR/J,
YBR/EiJ

BALB/cByJ,
BUB/BnJ, C57BL/6J,
CAST/EiJ, DBA/1J,
LP/J, NOD/ShiLtJ,
NZB/BINJ, RF/J,
RIIIS/J, WSB/EiJ

C57BL/6J,
C57BLKS/J,
C57BR/cdJ, C57L/J,
C58/J, SEA/GnJ,
SM/J

BALB/cJ,
BTBR T+ tf/J,
C57BLKS/J,
C57BR/cdJ, C58/J,
I/LnJ, MA/MyJ,
MOLF/EiJ,
NON/ShiLtJ,
SEA/GnJ, SM/J,
SWR/J

129S1/SvlmJ, A/J,
AKR/J, BALB/cJ,
BPH/2J, BPL/1J,
C57L/J, CAST/EiJ,
CBA/J, CE/J,
CZECHII/EiJ,
DBA/2J,
FVB/NJ, KK/HlJ,
LP/J, MOLF/EiJ,
PERA/EiJ, RF/J,
SPRET/EiJ,
WSB/EiJ

BALB/cByJ, BALB/cJ,
129S1/SvlmJ,
BTBR T+ tf/J,
BTBR T+ tf/J,
C3H/HeJ,C57BL/10J, C3H/HeJ, C57BL/6J,
BUB/BnJ, C57BL/10J, C57BR/cdJ, DBA/1J, FVB/NJ, I/LnJ, LP/J,
NZB/BINJ, RIIIS/J,
I/LnJ, NOD/ShiLtJ,
C57BR/cdJ, C57L/J,
SM/J, SPRET/EiJ,
NON/ShiLtJ,
CAST/EiJ, CBA/J,
SWR/J
NZB/BlNJ,
CZECHI/EiJ, DBA/1J,
NZW/LacJ, P/J,
DBA/2J, JF1/Ms,
RBF/DnJ, RIIIS/J,
MA/MyJ, MSM/Ms,
SEA/GnJ, SWR/J
NOD/ShiLtJ,
NZW/LacJ, PERA/
EiJ, PL/J, PWK/PhJ,
SL/J, WSB/EiJ

C57BL/6J,
C57BLKS/J, C58/J,
SJL/J, SM/J

A/J, C57BLKS/J,
C58/J, MOLF/EiJ,
NON/ShiLtJ

The Jackson Laboratory
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Atherogenic Diet and
Cholesterol Homeostasis

Professor Paigen characterized the effects of an
atherogenic diet on cholesterol homeostasis in the Mouse
Phenome Project strains in the same non-barrier and
barrier facilities (Paigen et al. 2000a, 2002). In non-barrier
facilities, mice were fed the atherogenic diet for eight weeks;
in barrier facilities, they were fed the diet for 17 weeks.
All raw data and protocols are published in the Mouse
Phenome Database, www.jax.org/phenome.
Cholesterol subphenotypes characterized in non-barrier
facilities included total plasma cholesterol, HDL plasma
cholesterol, non-HDL plasma cholesterol, % plasma HDL
cholesterol, free hepatic cholesterol, esterified hepatic
cholesterol, and total hepatic cholesterol.

Atherosclerosis

Cholesterol subphenotypes measured in barrier
facilities included HDL cholesterol, non-HDL cholesterol,
total cholesterol, fold change in HDL cholesterol, and nonHDL cholesterol.

Atherogenic Diet and Triglyceride Levels

Professor Paigen characterized the triglyceride levels of
the Mouse Phenome Project strains maintained in barrier
facilities before and after they were fed an atherogenic
diet for 17 weeks (Paigen et al. 2002). All raw data and
protocols are published in the Mouse Phenome Database,
www.jax.org/phenome.

Obesity Mutants
Several obesity mutants may be useful for researching
atherosclerosis. Paigen et al. (2000b) determined the dietinduced susceptibility to atherosclerosis of the following
four obesity mutants housed in non-barrier rooms:

B6(Cg)-Tubtub/J			

000562

Homozygotes for the tubby spontaneous
mutation develop late-onset obesity, recognizable
at three to four months in males and at four to
six months in females. The increased weight is
composed of excess adipose tissue. Blood glucose
is normal. Although plasma insulin levels rise
before obvious signs of obesity and may be 20
times above normal in six-month olds, tubby

BKS.Cg-m +/+ Leprdb/J				

mice do not become diabetic (Nishina et al. 1994;
Noben-Trauth et al. 1996). When maintained
in non-barrier facilities, despite having elevated
plasma total cholesterol, triglyceride, and HDL
cholesterol levels, B6 mice homozygous for the
Tubtub mutation are resistant to diet-induced
atherosclerosis (Table 2).

000642

Homozygotes for the Leprdb spontaneous
mutation with a BKS background become obese,
hyperinsulemic, and hyperglycemic. They are
polyphagic, polydipsic, and polyuric. Most die
by 10 months of age. They develop peripheral
neuropathy and myocardial disease. Wound
healing is delayed, and metabolic efficiency is

increased. When maintained in non-barrier
facilities, this strain is intermediately susceptible
to diet-induced atherosclerosis (Table 2).

The Jackson Laboratory
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B6.Cg-Ay/J			

000021

B6.Cg-Ay/J heterozygotes become obese but
only mildly diabetic (Reddi and Camerini-Davalos
RA 1988; Taylor et al. 1999). When maintained in

BKSChpLt.HRS-Cpefat/J		

non-barrier facilities, they are very susceptible to
diet-induced atherosclerosis (Table 2).

002391

Male BKSChpLt.HRS-Cpefat/J homozygotes
become diabetic, grossly obese, and severely
hyperglycemic (their glucose levels plateau
at about 400-600 mg/dl). Both sexes become
obese by six to eight weeks of age and are
distinguishable from wild-type littermates by
eight to 12 weeks of age. They are severely and

permanently hyperinsulinemic by four weeks
of age (JAX® Notes 2002; Naggert et al. 1995;
Nillni et al. 2002; Weide and Lacy 1991). When
maintained in non-barrier facilities, they are very
susceptible to diet-induced atherosclerosis
(Table 2).

Table 2. Effects of atherogenic diet on susceptibility to atherosclerosis in both sexes of four obesity mutants housed in nonbarrier facilities (Paigen et al. 2000b).
Resistant
mean lesion size: 0 µm2

Intermediately Susceptible
mean lesion size: 1-499 µm2

Very Susceptible
mean lesion size > 500 µm2

B6(Cg)-Tubtub/J
(000562)

BKS.Cg-m +/+ Leprdb/J
(000642)

B6.Cg-Ay/J (000021)
BKSChpLt.HRS-Cpefat/J (002391)

The Jackson Laboratory Mouse Heart,
Lung, Blood, and Sleep Disorders
Center
The Heart, Lung, Blood, and Sleep Disorders Center
(HLBS) is producing many chemically-induced mouse
models suitable for cardiovascular research. Characterized
and proven-heritable mutants are available to academic
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researchers for the cost of shipping only (for-profit
organizations are charged an additional fee). Instructions for
ordering are on the Center’s website, pga.jax.org.

JAX® Mice Models

Atherosclerosis

The Center maintains approximately 200 lines at one
of the following three stages of development: not yet proven
heritable, heritable and available to ship, and in the process of
being mapped. As of May 2008, 37 heritable and ready-to-ship
mutants and nine phenotypic deviants have cardiovascular
defects: 14 of the heritable mutants and one of the phenotypic
deviants have cholesterol disorders (Table 3).

Loci associated with high cholesterol and low HDL
have been mapped. For more detailed information about
these mapped mutants, consult the Mapped Mutant Matrix
at pga.jax.org/resources/mappedmutants.
Register to receive alerts of new JAX® HLBS mutants at
pga.jax.org/resources/alert_list.

Table 3. Number of heritable (ready-to-ship) mutants and phenotypic deviants suitable for cardiovascular research identified
by the HLBS Center (as of May 2008).
Number of
Heritable Mutants

Number of
Phenotypic Deviants

Trachycardia

2

2

Bradycardia (some with prolonged QT*
and PR* intervals)

2

1

Prolonged PR , QT , QTC intervals

2

1

Cholesterol Disorders

Cardiac Dysfunction

Cardiovascular Phenotypes

*

*

*

1

Dilated cardiomyopathy
High heart rate variability

2

Diet-induced hypercholesterolemia

1

Diet-induced hypercholesterolemia and
low HDL

1

Hypocholesterolemia and low HDL

2

High triglyceride levels

2
2

Low HDL
High HDL

6

High HDL and triglyceride levels

1

Diet-induced high HDL and
hypercholesterolemia

1

Hypertension

15

2

*QT, PR, and QTC refer to heart beat intervals displayed on an electrocardiogram.

The Jackson Laboratory
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Selected JAX® Mice Atherosclerosis Models
B6;129S6-Abcg5/Abcg8 tm1Hobb/J		

004670

Homozygotes for these targeted mutations
of the ATP-binding cassette, sub-family G
(WHITE), member 5 (Abcg5) and ATP-binding
cassette, sub-family G (WHITE), member
8 (Abcg8) genes are viable and look and behave
normally. Their plasma sitosterol levels are

B6.129P2-Apoa1tm1Unc/J		

002055

Homozygotes for this apolipoprotein A-I
(Apoa1) targeted mutation appear to develop
normally despite having no APOA1 protein.
Additionally, after being fasted overnight, they
have severely reduced levels of plasma cholesterol
and HDL-cholesterol, and they are deficient in
alpha-migrating HDL particles (Williamson

C57BL/6-Tg(APOA1)1Rub/J		

The Jackson Laboratory

Major et al. (2001) found that atherosclerotic
lesions in mice Apoe-deficient and also
transgenic for human APOA1 under the control
of a macrophage-specific scavenger receptor-A
promoter are 96% smaller than those in mice
that are only Apoe-deficient. Atherosclerosis
resistance in these mice has been attributed to
the production of human APOA1 protein and
the consequently increased cholesterol efflux by
macrophages in the artery wall.

002053

Mice with this targeted mutation of the
apolipoprotein B (Apob) gene produce a truncated
form of the apolipoprotein B protein (APOB70)
and no APOB100, resulting in a condition similar
to human familial hypobetalipoproteinemia.
These mice express normal amounts of APOB48.
Homozygotes have greatly reduced levels of

14

et al. 1992). Although ApoaI deficiency delays
cholesterol absorption, cholesterol is eventually
absorbed because of the compensatory Apob
pathway. Nonetheless, long-term studies involving
multiple feedings indicate significant reduction in
cholesterol absorption after four days (Iqbal and
Hussain 2005).

001927

Considerable evidence indicates that a high
concentration of APOA1 in the artery wall
enhances cellular cholesterol efflux and protects
against atherosclerosis. Mice homozygous for the
human apolipoprotein A-I (APOA1) transgene
(under control of its natural promoter) are viable,
fertile, and normal-sized. They have twice as
much total plasma cholesterol but over four times
less mouse APOAI than normal. They have a
reduced susceptibility to diet-induced fatty streak
lesions (Rubin et al. 1991).

B6.129P2-Apob tm1Unc/J		

30 times higher than normal. Their biliary,
plasma, and liver cholesterol levels are low. Their
plasma and liver cholesterol levels increase
rapidly (2.4 and 18 fold, respectively) following
cholesterol feeding (Yu et al. 2002).

plasma APOB, beta-lipoproteins, total cholesterol,
plasma triglycerides, fasting chylomicronemia,
and HDL cholesterol. Homozygotes also have a
high incidence of exencephaly and hydrocephaly
(Homanics et al. 1993).

JAX® Mice Models
B6.129P2-Apoetm1Unc/J		

Atherosclerosis
002052

Apolipoprotein (apoE) is a glycoprotein
synthesized in the liver, brain, and other tissues
in both humans and mice. It is a structural
component of all lipoprotein particles other than
LDL. One of its most important functions is to
serve as a high affinity ligand for the apoB and
apoE (LDL) receptor and for the chylomicron
remnant receptor, thereby allowing the uptake of
apoE-containing particles by the liver (Jawien et
al. 2004).
Because they are hypercholesterolemic and
spontaneously develop arterial lesions, Apoedeficient mice are one of the most relevant models
for atherosclerosis research. They develop lesions
more quickly if fed a Western diet (containing
21% fat and 0.15% cholesterol), and even more
quickly if fed a high-cholesterol diet (containing
15% fat, 1.25% cholesterol, and 0.5% cholic acid)
(Jawien et al. 2004).

B6.129-Apoetm1Unc Ldlrtm1Her/J		

002246

Mice homozygous for both Apoe and the
Ldlr targeted, null mutations develop severe
hyperlipidemia and atherosclerosis. Even
when fed a regular chow diet, they usually
develop a more severe atherosclerosis than do

B6.129S7-Ldlrtm1Her/J		

The progression of atherosclerosis in this model
is very similar to that in humans. By three months
of age, homozygous mutants develop fatty streaks
in the proximal aorta. With age, they develop
more lesions with relatively less lipid but more
elongated cells, typical of the advanced stage preatherosclerotic lesions.
Because atherosclerotic plaques in coronary
arteries are particularly critical, future genome
scans in mice should perhaps include coronary
atherosclerosis as a phenotype (Wang et al. 2005).
Advanced atherosclerotic lesions do occur in the
coronary arteries of Apoe- and/or Ldlr-deficient
mice and in Scarb1-deficient mice fed either chow
(Braun et al. 2002) or a high-cholesterol diet
(Caligiuri et al. 1999; Calara et al. 2001).

Apoe-deficient mice. These mice do not have to
be fed an atherogenic diet when used to test the
anti-atherosclerotic effects of compounds (Jawien
et al. 2004).

002207

These low density lipoprotein receptor-(Ldlr-)
deficient mice have high serum cholesterol levels
(200-400 mg/dl) and very high levels
(> 2,000 mg/dl) when fed a high fat diet (levels in
normal mice are 80-100 mg/dl). Although they

develop atherosclerotic lesions spontaneously
when fed a chow diet, the lesions are small and
develop slowly. The lesions develop much faster
in mice fed either a high cholesterol or a Western
diet (Jawien et al. 2004).

The Jackson Laboratory
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B6.129-Pctp tm1Bor/J			

Atherosclerosis
006607

Mice homozygous for this targeted mutation of
the phosphatidylcholine transfer protein (Pctp)
gene are viable, fertile, and look and behave
normally. PCTP is not detected in the liver cytosol
of eight day old homozygotes. The lipid content
and composition of bile and lung surfactant
secretions are normal. Plasma cholesterol
and phospholipid levels are not affected in
homozygotes fed a normal chow diet, but the

B6.129P2-Pltp tm1Jia/J		

003918

Homozygotes for this targeted mutation of
the phospholipid transfer protein (Pltp) gene are
viable, fertile, and look and behave normally.
Their lungs and liver produce no Pltp mRNA.
No plasma PLTP activity is detected. They have
marked decreases in plasma HDL phospholipids
(66%), cholesteryl esters (69%), free cholesterol

B6;129S2-Scarb1tm1Kri/J		

The Jackson Laboratory

125% higher, respectively, than they are in
wild-type controls. Additionally, cholesterol
levels in the adrenal tissues of heterozygotes and
homozygotes are 42% and 72% lower, respectively,
than they are in wild-type controls. The plasma
concentrations of APOAI, the major protein in
HDL, in these mutants is comparable to that of
wild-type controls (Braun et al. 2002).

002053

Homozygotes for the Apobtm1Unc targeted
mutation produce a truncated form of the
apolipoprotein B protein APOB70 and no
APOB100, resulting in a condition similar to
human familial hypobetalipoproteinemia.
These mice express normal amounts of APOB48.
Homozygotes have greatly reduced levels of

16

(70%), and apoAI. When fed a high fat/high
cholesterol diet, similar reductions are observed,
as are increases in VLDL and LDL phospholipid,
free cholesterol, and cholesteryl ester (Jiang et al.
1999, 2001; Qin et al. 2000).

003379

The class B, type I scavenger receptor Scarb1
is a cell surface HDL receptor that can recognize
the apolipoproteins on the surface of the HDL
particle. It plays a key role in determining the
levels of plasma lipoprotein cholesterol (primarily
HDL) and the accumulation of cholesterol stores
in the adrenal gland. The plasma cholesterol
(primarily HDL) concentrations in Scarb1tm1Kri
heterozygotes and homozygotes are 31% and

B6.129P2-Apob tm1Unc/J		

accumulation of small alpha-migrating HDL
particles increases. When mice are fed a high fat,
high cholesterol, cholate-containing lithogenic
diet, biliary concentrations of phospholipids,
cholesterol, and bile salts decrease, but hepatic
accumulations of phospholipids and cholesterol
increase. When mice are fed a high fat diet, HDL
particles are normal-sized, but plasma cholesterol
and phospholipid concentrations are increased.

plasma APOB, beta-lipoproteins, total cholesterol,
plasma triglycerides, fasting chylomicronemia,
and HDL cholesterol. Homozygotes also have a
high incidence of exencephaly and hydrocephaly
(Homanics et al. 1993).

JAX® Mice Models
DBA/1-Abca1tm1Jdm/J		

Atherosclerosis
003897

Many homozygotes for this targeted
mutation of the ATP-binding cassette, subfamily A (ABC1), member 1(Abca1) gene die
perinatally. Autopsied pups exhibit perivisceral
hemorrhaging. Pups that survive beyond birth
have no detectable Abca1 gene transcript in
the liver. Homozygous females have impaired
placental development and are unable to
produce litters. Plasma lipids and lipoproteins
are markedly reduced; plasma cholesterol is
decreased by approximately 70%; HDL-C and

STOCK Cav1tm1Mls/J			

apoAI are decreased by greater than 99%; and
LDL-C and apoB are reduced 70% and 20%
respectively. Other characteristics observed are
an increase in intestinal absorption of dietary
cholesterol, an impaired ability of macrophages
to engulf apoptotic cells, and an accumulation of
lipid-rich macrophages and type II pneumocytes
in the lungs. The pathophysiology of these mice
is similar to that associated with Tangier disease
(Calpe-Berdiel et al. 2005; Francone et al. 2003;
McNeish et al. 2000).

004585

Homozygotes for this targeted mutation of
the caveolin, caveolae protein 1 (Cav1) gene are
viable, fertile, and look and behave normally.
They are intolerant to exercise and slightly
hyperphagic. When four to five months old, they
are often smaller than their wild-type littermates,
and, when a year old, weigh five to seven grams
less than those littermates. They are resistant to
diet-induced obesity. They produce a reduced
amount of white adipose tissue comprised of
abnormally small adipocytes, but they have
enlarged and hyperplastic brown adipose tissue.
Their lipid metabolism and uptake is disrupted,
resulting in elevated levels of serum triglycerides
and free fatty acids, and reduced levels of leptin.

Isolated segments from their aortic tissues
have a diminished vasoconstriction response
to the alpha-1-adrenergic receptor agonist,
phenylephrine, and an enhanced vasorelaxation
response to acetylcholine. They have thickened
alveolar septa, hypercellularity, reduced alveolar
spaces, an increased density of basement
membranes and reticulin fibers, and an increased
number of endothelial cells. MEF cells derived
from these mice are twice as proliferative and
denser at confluence than are those of wildtype littermates. Their endothelial cells lack
caveolae (plasmalemmal vesicles), and caveolar
endocytosis is impaired (Razani et al. 2001).

The Jackson Laboratory
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Blood Pressure
The Mouse Phenome Project Strains

Strain

Diastolic
pressure

129T2/SvEmsJ

72.5 ± 6.1

115.7 ± 8.7

A/J

66.8 ± 7.6

106.7 ± 5.6

AKR

79.2 ± 6.4

121.2 ± 2.9

ALS/LtJ

76.1 ± 5.1

120.6 ± 6.6

BALB/cAn

72.3 ± 3.6

107.8 ± 3.6

BTBR

62.2 ± 7.6

101.4 ± 2.7

C3H/HeJ

66.8 ± 3.5

100.5 ± 3.2

C57BL/6J

73.2 ± 2.9

114.6 ± 5.3

C57BLKS/J

71.4 ± 5.0

115.4 ± 3.0

CBA/J

71.1 ± 3.2

106.0 ± 7.0

• Kitten (2003) performed a multi-system analysis of mouse
physiology (including various blood pressure and other
cardiovascular subphenotypes) in seven JAX® Mice
inbred strains.

DBA/1J

69.8 ± 3.4

103.4 ± 2.5

DBA/2J

68.4 ± 5.3

107.8 ± 3.5

FGS/Nga

74.4 ± 1.8

111.8 ± 6.3

FVB/N

70.8 ± 4.5

110.0 ± 4.9

• Sugiyama and Tsukahara et al. (2007) and Sugiyama et al.
(2002) determined the systolic and diastolic blood pressure
of 25 inbred mouse strains, most of them
JAX® Mice strains (Table 4).

KK/Ta

66.8 ± 1.2

111.8 ± 4.1

LP

62.1 ± 11.1

102.7 ± 7.2

MRL

77.1 ± 10.5

113.5 ± 6.5

NOD

85.2 ± 9.1

127.2 ± 4.4

NON

64.4 ± 6.1

104.8 ± 6.2

NZO/HILtJ

86.6 ± 6.9

132.4 ± 3.1

NZW

62.5 ± 8.7

106.9 ± 8.2

PL

70.8 ± 70.6

118.9 ± 7.6

RIIIS

70.3 ± 10.9

115.3 ± 6.7

SJL/J

67.7 ± 2.1

100.6 ± 4.4

SWR/J

86.1 ± 4.7

127.1 ± 3.0

Blood pressure phenotypes of numerous JAX® Mice strains
have been characterized and published in the Mouse Phenome
Database, www.jax.org/phenome:
• Deschepper and Gallo-Payet (2004) measured the
systolic blood pressure and morphologic phenotypes of
cardiovascular-related organs in 13 JAX® Mice inbred strains.
• Gavras et al. (2003) measured the effects of diet on blood
pressure and heart rate in 11 JAX® Mice inbred strains.
• Svenson and Smith (2005) measured the systolic blood
pressure, blood pressure variability across tests, pulse, and
pulse variability across tests in 14 JAX® Mice inbred strains.

HLBS Mutants

The HLBS Center has produced 15 heritable
(ready-to-ship) mutants and two phenotypic deviants suitable
for hypertension research (Table 3, page 13).

Systolic
pressure

Table 4. Mean diastolic and systolic blood pressures
(±SD) in 25 inbred mouse strains (Tsukahara et al.
2004; Sugiyama et al. 2002).
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Selected JAX® Mice Blood Pressure Models
B6.129P2-Nos3tm1Unc/J		

002684

Homozygotes for this targeted mutation of the
nitric oxide synthase 3, endothelial cell (Nos3) gene
are viable and fertile. Their blood pressure is about
20 mmHg higher than that of wild-type siblings,

BPH/2J			
BPL/1J			
BPN/3J			

003005
003006
003004

BPH/2J, BPL/1J, and BPN/3J are descended
from an eight-way cross from which hypertensive
and hypotensive mouse lines were selected
(Schlager and Sides 1997).
BPH/2J mice are hypertensive. By five weeks of
age, they have elevated systolic blood pressures;
by 150 days of age, their blood pressures are
60mmHg higher than those of BPL/1J mice. They
have higher heart rates, larger hearts and kidneys,
and higher hematocrit than do BPL/1J mice,
and lower renin, aldosterone, and angiotensin I
levels than do BPL/1J and BPN/3J mice. BPN/3J
mice are normotensive. They were inbred at the
same time as and from the same parental strain
as BPL/1J and BPN/3J, but in the absence of
any selection pressure. They are a normotensive
control for hypertensive BPH/2J mice and
hypotensive BPL/1J mice.
The original high blood pressure (HBP) and
low blood pressure (LBP) selected lines from
which the three strains were inbred had several
biochemical and physiological differences that
have not been re-examined in the inbred strains.
These include differences in brain catecholamines,
calmodulin concentrations, heat sensitivity,

B6.129P2-Agtr1tm1Unc/J		

and they have a decreased heart rate. Females
weigh less than normal wild-type siblings. They
are insulin resistant in the liver and peripheral
tissues (Shesely et al. 1996).

alcohol preference, and longevity. The differences
in longevity are striking: the hypotensive selected
lines live an average of 200-300 days longer than
do the hypertensive selected line. Genetic analysis
suggested that three to five genes are responsible
for the difference in blood pressures between
BPH/2 and BPL/1 mice. A recent genome scan
of (BPH/2 x BPL/1)F2 progeny revealed three
chromosome locations co-segregating with blood
pressure. Two of these sites were verified by
candidate gene co-segregation: angiotensinogen
on Chr 8 and mouse kallikrein binding protein
(Serpina3c) on Chr 12 (Schlager and Sides 1997;
Uddin and Harris-Nelson 2004).
Observations by some of our scientists (Paigen
and Svenson, pers. comm.) suggest that the
BPH/2J strain may be a model of preeclampsia.
It is a subline originating from an eight-way cross
performed by Schlager and Sides (1997) and
appears to have some of the same preeclampsia
phenotypes (including small litters of one or two
pups) as a different subline from the same cross
(Dokras et al. 2006; Davisson et al. 2002). We
are in the process of characterizing BPH/2J to
determine its potential as an preeclampsia model.

002682

Homozygotes for this targeted mutation of
the angiotensin II receptor, type 1a (Agtr1) gene
are viable and fertile. Their blood pressures are
approximately 24 mmHg lower than those of
normal wild-type siblings and do not respond

to angiotensin II infusions. Blood pressures of
heterozygotes are approximately 12 mmHg lower
than those of wild-type siblings and respond
qualitatively to angiotensin II infusions
(Ito et al. 1995).

The Jackson Laboratory
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Heart Disorders
HLBS Mutants
The HLBS Center has produced 13 mutant models (eight
heritable, and ready-to-ship) for researching heart disorders
(see Table 3, page 13).

Selected JAX® Mice Models
B6;129S-Gja1tm1Kdr/J		

002201

Homozygotes for this targeted mutation of
the gap junction membrane channel protein
alpha 1 (Gja1) gene die at birth. The cause of
death is a failure in pulmonary gas exchange
caused by a swelling and blockage of the right
ventricular outflow tract from the heart. The
cardiac abnormality involves a delayed looping
of the ascending limb of the heart tube, which
includes the right ventricle and the outflow tract.

B6Ei.Cg-Atp7aMo-blo/J		

002044

Female heterozygotes for the blotchy allele
(Atp7aMo-blo), a targeted mutation of the ATPase,
Cu++ transporting, alpha polypeptide (Atp7a)
gene, are viable and fertile. They have irregular
patches of light-colored fur. Hemizygous males
and homozygous females have reduced viability,
and many are infertile. Hemizygotes and
homozygotes are light all over with no blotching,

B6.129P2-Nos3tm1Unc/J		

The Jackson Laboratory

heart rate. Females weigh less than normal
wild-type siblings (Feng et al. 2002; Li et al. 2004;
Ojaimi et al. 2005).

005642

Homozygotes for this targeted mutation of
the clusterin (Clu) gene are viable, fertile, and
look and behave normally. Clusterin is a widely
expressed circulating glycoprotein of unknown
function associated with Alzheimer’s disease,
cerebral palsy, stroke, apoptosis, autoimmune
myocarditis and other inflammatory injuries,
kidney disease, and skin carcinogenesis (Imhof
et al. 2006; McLaughlin et al. 2000). It plays a
20

are usually small, and occasionally have deformed
hind legs. Most hemizygotes and homozygotes
have defective aortic elastin and die of an aortic
aneurysm. Hemizygous males have enlarged air
spaces in their lungs (emphysema), probably
because they have defective elastin and collagen
(Andrews et al. 1975; Brophy et al. 1988).

002684

Homozygotes for this targeted mutation of the
nitric oxide synthase 3, endothelial cell (Nos3)
gene are viable and fertile. They have a low

B6.Cg-Clutm1Jakh/J			

This predisposes homozygotes to malformations
of the subpulmonary outflow tract and tricuspid
valve. The mutation also predisposes homozygotes
to lens cataracts and causes a severe reduction
of germ cell numbers. Both neonatal and adult
heterozygotes have slow ventricular epicardial
heartbeats (Reaume et al. 1995).

central role in the remodeling of ischemic damage
(Imhof et al. 2006). Clu-deficient mice,
particularly females, develop more severe myosininduced myocarditis than do wild-type mice,
suggesting that clusterin limits the progression of
autoimmune myocarditis and protects the heart
from postinflammatory tissue destruction
(McLaughlin et al. 2000).

JAX® Mice Models

Metabolic Syndrome

Metabolic Syndrome (Syndrome X)
B6.129S7-Ldlrtm1Her/J 		

002207

Until recently, few animal models were known
to display the constellation of obesity, type 2
diabetes, hypertension, atherosclerosis, and
other abnormalities collectively called metabolic
syndrome or syndrome X. Males of this Ldlrdeficient JAX® Mice strain may be such a model.
Ldlrtm1Her homozygotes have long been used as
a model for cardiovascular disease, and recent
studies indicate that they may be excellent models
of diet-induced metabolic syndrome. Males fed a

B6.129-Ppargtm2Rev/J			

diabetogenic diet develop hypertriglyceridemia,
high serum cholesterol levels, hyperleptinemia,
slightly higher insulin and moderately higher
plasma glucose levels than do C57BL/6 mice
fed a diabetogenic diet, obesity, high vascular
calcification, atherosclerotic plaques comparable
to those that form in mice of the same strain fed
a chow diet, and elevated free fatty acid levels
(Merat et al. 1999; Towler et al. 1998, Schreyer
et al. 2002).

004584

The B6.129-Ppargtm2Rev/J strain, developed in
the laboratory of Dr. Ronald Evans at The Salk
Institute by Dr. Yaacov Barak, currently at The
Jackson Laboratory, possesses loxP sites flanking
exons 1 and 2 of the peroxisome proliferator
activated receptor gamma (Pparg) gene, which
is abundantly expressed in adipocytes. In
conjunction with a Cre recombinase-expressing
strain, this strain can be used to generate tissuespecific Pparg mutants. For example, when this

strain is mated to B6.Cg-Tg(Fabp4-cre)1Rev/J
(005069), offspring are produced in which Pparg
is deleted. These offspring develop progressive
lipodystrophy and late onset syndrome X-like
symptoms, including modestly elevated plasma
free fatty acid and triglyceride levels, decreased
plasma leptin and ACRP30 levels, increased
hepatic glucogenesis, and increased insulin
resistance (He et al. 2003; Hevener et al. 2003).

The Jackson Laboratory
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JAX® Services
JAX® Services is a comprehensive and integrated set of
mouse breeding and research services designed to provide
you with efficient and cost-effective solutions to your mousebased research. The services are based on nearly 80 years of
experience in mouse husbandry and genetic research and are
conducted in accordance with the highest standards of animal
health and genetic quality.
Several services that may be appropriate for cardiovascular
research are described below. For more information on

In Vivo Services
these and other services, please contact your Regional
Representative (contact information can be found on the
following website: www.jax.org/jaxmice/services/manager),
visit the JAX® Services website, www.jax.org/jaxmice/
services/invivo, or contact JAX® Services at
jaxservices@jax.org, 1-800-422-6423, or 1-207-288-5845.

JAX® In Vivo Services
We provide fully customizable target validation and
efficacy testing services with access to the world’s largest
collection of specialized mouse models. Our Study Directors
and research scientists bring their expertise and collective
knowledge of mouse physiology and genetics research to
work for you.
Our state-of-the-art phenotyping laboratory provides a
broad array of high-throughput, cost-effective, and
non-invasive test platforms for model characterization,
evaluation of key physiological parameters, drug target
validation, and drug efficacy testing (Table 5). Our in-house
services are complemented by a network of providers to offer
comprehensive disease endpoint measurements.

We have expertise with a variety of therapeutic areas,
including atherosclerosis, osteoporosis, subcutaneous
and orthotopic xenograft models of cancer, inflammatory
bowel disease, blood disorders, neuromuscular disease,
regenerative medicine, autoimmune disorders, pain models,
asthma, dermatology, and metabolic disorders, including
diabetes and obesity. Our dedicated, experienced staff help
select the most clinically relevant model for your protocol.
We have performed in vivo studies in over 100 mouse
models to date.
JAX® In Vivo Services are highly customizable. We manage
entire projects and work closely with you to ensure that
custom protocols are properly executed

Table 5. Summary of JAX® In Vivo Services.
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Compound Dosing
IP, IV, SC, PO, ID
High pressure tail vein injections
Inhalation
In the food or water
Intramuscular, intrarectal
IV catheters
Osmotic minipumps (SC or IP)
SC drug pellets

Experimental Methods
Biospecimen collection
Digital caliper measurements
In vitro cell preparation: cell isolation, culture,
characterization
Mouse model induction
Necropsies, tissue harvests
Surgical techniques
SC xenograft and orthotopic transplantation
Stem cell engraftment

Physiological and Behavioral Tests*
Activity Monitoring, including locomoter, rearing
Body tissue composition by DEXA and MRI
C02 production/O2 uptake, food & water intake
Glucose tolerance, insulin tolerance, glucose measurement
Heart rate, ECG
Locomotor anxiety test analyzed by SMART software
Morris water maze, Radial arm maze
Respiratory function by Whole Body Plethysmograph
Rotorod, grip strength, gait analysis
Systolic and diastolic blood pressure, pulse
Thermal pain reflex

Supporting Services
Bioanalytical
Blood and urine glucose
CBC
Clinical chemistry
Histological services and IHC
Immunophenotyping
Lipid distribution
Metabolic assays
Multiplex analysis of serum hormones and cytokines
Access to specialized imaging: biophotonic, MRI,
micro-CT, PET
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JAX® Services

VCD-induced Menopause

VCD-induced Menopause
We can produce mouse models that mimic the
physiological changes occurring in human perimenopause,
enabling researchers to better understand the associations
between both menopause and hormone replacement therapy
and susceptibility to heart disease.
The only rodent models previously available for modeling
menopause were ovariectomized (OVX) rats and mice.
However, almost 90% of menopausal women still have
their ovaries. Our service uses the industrial chemical
4-vinylcyclohexene diepoxide (VCD) to selectively accelerate
the natural loss of small primordial and primary follicles
without affecting the ovary or other tissues, resulting in an
endocrine state that more closely mimics human menopause
(Fig. 1) (Mayer et al. 2002).
VCD-induced menopause is a particularly powerful tool
because it works with most mouse strains, including models
of atherosclerosis. For example, Mayer et al. 2004, 2005)
found that when VCD-induced menopausal low-density
lipoprotein-(Ldlr-) deficient mice (B6.129S7-Ldlrtm1Her/J,
002207), which are susceptible to atherosclerosis, receive

17β-estradiol supplements, they develop significantly fewer
atherosclerotic plaques than do either non-supplemented
controls or non-supplemented OVX mice.
VCD-induced menopause may be particularly
appropriate for cardiovascular research when used with
the following four JAX® Mice strains: C57BL/6J (000664),
an atherosclerosis-susceptible strain; C3H/HeJ (000659),
an atherosclerosis-resistant strain; B6.129S7-Ldlrtm1Her/J
(002207), a strain with normally high serum cholesterol
levels and extremely high levels when fed an atherogenic
diet; and B6.129P2-Apoetm1Unc/J (002052), another strain
with high serum cholesterol levels. A study by our Animal
Husbandry and Performance Group demonstrated the
efficacy of VCD-induced menopause in these strains. VCD
treatments significantly decreased the number of primordial
and primary follicles, resulting in a significant increase in
FSH levels (JAX® NOTES 2007). For additional cost, this
service can be adapted to other strains.

Figure 1. Cyclicity, estrogen levels, and FSH levels
are similar in VCD-induced mouse and human
menopause. The OVX mouse goes into menopause
quickly and skips peri-menopause, (the one to 10
years in humans before menstrual cycles cease). Postmenopause refers to the year after peri-menopause.
Values for VCD-induced menopause are relative to
the beginning of the 15-day VCD injection protocol.
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JAX® Services

Surgical and Tissue Collection

JAX® Surgical & Tissue Collection Services
Our expert surgeons can perform over 60 types of
standard and custom surgical procedures. Conventional
techniques can be modified, or new ones can be developed
to meet even the most demanding research requirements.
All surgeries are performed at an appropriate health status
in surgical suites of a barrier facility. We can also collect and
provide you with tissues or fluid samples. Table 8 below lists
most of our surgical procedures and biospecimens. For a
complete list and prices, please visit our website,
www.jax.org/jaxmice/services/surgical_pricing.
Foamy macrophages in the subendothelial space of a
mouse aorta.
Table 8. Selected surgical procedures and biological samples available from JAX® Services.
Surgical Procedures
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
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Adrenalectomy
Adrenal demedullation
Brown adipose fat denervation
Castration - Orchiectomy
Catheter (jugular, femoral, carotid)
Subcutaneous hormone pellet implant
Hysterectomy
Intracerebroventricular cannulation
Intrathymic injections
Kidney capsule implant
Nephrectomy (5/6 and unilateral)
Olfactory bulbectomy
Osmotic pump implants
Ovarian transplant
Ovario-hysterectomy
Ovariectomy
Skin graft (body or tail)
Sialectomy
Splenectomy
Subq implant
Telemetry Implant (PA-C10 BP monitor)
Thymectomy
Thyroid-parathyroidectomy
Vasectomy
Vagotomy

The Jackson Laboratory

Tissue and Fluid Samples
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Bile
Blood, Serum, Plasma (pooled, non-pooled)
Adrenal glands
Aorta
Bone (vertebrae and femur)
Bone marrow
Brain and Spinal cord
Diaphragm
Embryonic tissue
Eyes, Retina
Fat (brown and white depots)
Head
Heart, Liver, Kidneys, Lungs
Leg
Mammary glands
Ovaries, Testicles, Uterus, Prostate
Pineal gland, Pituitary gland
Polyps
Salivary gland - Submandibular
Skeletal muscle
Skin (with or without hair)
Spleen, Thymus
Stomach, Small intestine, Colon, Pancreas

JAX® Services

Breeding and Colony Management

Breeding and Colony Management Services
Offered in Maine, and California, our Breeding and
Colony Management Services are designed to save you
time, space, money, and to simplify all aspects of managing
your mouse colonies.
JAX® Breeding and Colony Management services support
your research with the following:
• Nearly 80 years of experience in mouse genetics and
colony management
• State-of-the-art technologies in reproductive science
and genetic analysis
• World-class expertise with an array of in vitro
fertilization (IVF) techniques
• Experience in optimizing animal housing space
to deliver standard and customized breeding projects
on schedule, on budget, and according to
your specifications
• Capability to rapidly expand breeding colonies by
drawing from large quantities of breeding stock
• Breeding strategies customized to your needs, whether
for large or small quantities of mice, from pedigreed
stock to preserve genetic integrity

JAX® Breeding Service
This service helps you quickly and efficiently achieve your
objectives, whether to relieve capacity constraints at your
facility, rederive mice to improve the health of your colonies,
or manage complex, multiple-gene crossbreeding projects.
Using investigator-supplied or JAX® Mice strains, this service
maintains and ships mice to you as needed. Our California
facility can also handle projects which require housing mice
in flexible film isolators.

JAX® Dedicated Supply Service

Many of our strains are available only from our
cryopreserved repository or from small colonies in limited
quantities. Our Dedicated Supply Service can custom build
a colony of these strains, so you receive the mice you need
when you need them. Our Dedicated Supply personnel
know all the tricks of the trade for maintaining difficult
strains and for expanding colonies of low-demand strains
efficiently and cost-effectively.

JAX® Speed Expansion Service

Expanding colonies to meet increased demand or to
produce a burst of same-age mice can be expensive and time
consuming. Using IVF techniques, we can do this rapidly
and cost-effectively. This service is particularly useful for
quickly producing large quantities of specific pathogen free
(SPF), same-age mice.

The Jackson Laboratory
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JAX® Services

Cryopreservation and Recovery

Cryopreservation and Recovery Services
JAX® Sperm Cryopreservation &
Recovery Service

Our scientists have developed the first truly reliable and
cost-effective sperm cryopreservation and recovery service
for knock-out and transgenic strains with common genetic
backgrounds. We recover cryopreserved sperm and use
them to quickly produce a large colony of single-age SPF
mice. This service includes a quality control check (IVF
rate for the frozen sperm) and three years of liquid nitrogen
storage (additional years of storage can be purchased).

JAX® Custom (Embryo)
Cryopreservation Service

We can cryopreserve embryos of homozygous and hemi/
heterozygous inbred, mutant, and genetically modified
lines of mice. Cost varies depending on strain background,
fertility, and the number of mice provided. This service
includes five years of liquid nitrogen storage (additional
years of storage can be purchased).

Combined JAX® Speed Rederivation and
JAX® Sperm Cryopreservation Service

In this combined service, our JAX® Speed Rederivation
Service uses IVF to quickly rederive your mouse strain
to SPF status, and, at no extra cost, our JAX® Sperm
Cryopreservation & Recovery service cryopreserves
sperm from the strain for three years, protecting it from
accidental loss or contamination and freeing up valuable
mouse room space. This combined service is applicable for
strains with transgenes, targeted mutations, or chemicallyinduced mutations on the most commonly used genetic
backgrounds: C57BL/6J, FVB/NJ, NOD/ShiLtJ, BALB/cByJ,
BALB/cJ, DBA/1J, DBA/2J, C3H/HeJ, hybrid combinations
of these strains, and B6;129 hybrids.
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Our new JAX® Sperm Cryopreservation and Recovery
Service produces much higher embryo fertilization rates
from cryopreserved sperm than traditional methods.

JAX® Services

Genetic Analysis and Research Services

JAX® Genetic Analysis and Research Services
Our scientists have developed a panel of 2,199 informative
and easily-assayed single nucleotide polymorphic (SNP)
markers. These markers are an average of approximately
1.5 Mb or 0.75cM apart and often represent the informative
allele in at least two strains (Petkov et al. 2004a, 2004b). We
use this SNP panel for many of our services, including those
described below.
Using our SNP panel, we can characterize the genetic
make-up of virtually any mouse strain. As examples, we can
detect inter-strain genetic contamination, determine the
degree of congenicity in congenic strains, and detect cryptic
unlinked segments of residual donor DNA in congenic strains.

JAX® Speed Congenic Development Service

This service uses a marker-assisted breeding strategy to
produce congenic strains in only 15 to 18 months, reducing
the number of mice needed, as well as facility, equipment,
and personnel costs.

JAX® Genome Scanning Service

We designed this service for those of you who prefer to
construct your own congenic or consomic strains but wish to
take advantage of our SNP-marker panel to type and select
the offspring for each backcross. The process is easy: simply
send us tail samples from backcross offspring (minimum
of six to 10 recommended per generation), and we type the
tails and tell you which mice to use for the next backcross

JAX® Gene Expression Service

Accelerate your research by using JAX®'s well established
Gene Expression Service. The service includes nucleic
acid preparation, chip/array hybridization, and detailed
statistical analysis, using unique statistical tools developed
at The Jackson Laboratory. We have successfully analyzed
thousands of mouse tissues for our own scientists, and
are now pleased to offer this service to the broader
scientific community.

JAX® Gene Mapping Service

Using our SNP-marker panel, we can analyze mouse
tissue or processed DNA samples from F2 or N2 progeny
and localize a gene of interest. We can also help you select
the most appropriate strains to produce the F2 or N2
progeny. You receive results approximately six weeks after we
complete the crosses and collect tissue samples. This service
is appropriate for mice with single-gene mutations.

JAX® SNP-Assisted QTL Mapping Service

QTL mapping has become a very important tool for
finding the alleles that contribute to complex human
diseases, such as atherosclerosis and hypertension. These
diseases are continuous and modulated by a group of alleles
interacting with each other and the environment. Using our
SNP marker panel, we can locate and estimate the effect of
contributing alleles.

The Jackson Laboratory
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Online Resources
Online Resources for Mouse-based Cardiovascular Research
JAX® Mice Database

You can find more information on over 250 JAX® Mice
models suitable for cardiovascular research (including
those described herein) in the JAX® Mice Database. Using
the Quick Query Form (www.jax.org/jaxmice/query),
you may search the database using gene or allele symbols,
common names, stock numbers, keywords, phenotype terms
from the Mouse Phenotype Ontology vocabulary in the
Mouse Genome Database, human disease terms from the
Online Mendelian Inheritance in Man (OMIM) vocabulary,
or research areas.
Select the strain name to view the Strain Data Sheet.
Each Strain Data Sheet includes nomenclature information,
genetic and phenotypic characteristics, strain development
information, research applications, references, and
availability and pricing information.

Mouse Phenome Database

The Mouse Phenome Database (MPD, www.jax.org/
phenome) is the database for the Mouse Phenome Project,
a coordinated international effort to establish a collection
of baseline phenotypic data for a set of commonly used
and genetically diverse inbred mouse strains. Housed at
The Jackson Laboratory, The MPD includes baseline and
diet-induced phenotypic data for many cardiovascular
phenotypes, including cholesterol and triglyceride levels,
blood pressure, and susceptibility to atherosclerosis.
The database characterizes these and other phenotypes
by strain and sex. Investigators may download protocols
and raw data, review related data published in the scientific
literature, use query tools to analyze data, review current
project information, participate in the Mouse Phenome
Project, and subscribe to “PHENOME-LIST,” a forum for
discussing Phenome Project-related items. The Mouse
Phenome Database is fully integrated with the Mouse
Genome Database (www.informatics.jax.org).
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JAX® HLBS Center

The Jackson Laboratory’s Center for New Mouse Models
of Heart, Lung, Blood, and Sleep Disorders (HLBS) is one of
five Programs for Genomic Applications (PGAs) established
in September, 2000, by the National Heart, Lung, and Blood
Institute to advance functional genomic research related to
heart, lung, blood, and sleep (www.nhlbi.nih.gov/resources/
pga). The goal of The Jackson Laboratory PGA is to provide
the biomedical research community with new information,
tools, and resources for understanding the genetic bases
of atherosclerosis, hypertension, lung function, blood
formation, thrombosis, obesity, and sleep function.
Among the new tools produced by the Center are
chemically-induced mutant mice, many of them suitable
for cardiovascular research. To produce these mutants, the
Center uses N-ethyl-N-nitrosourea (ENU) and B6 mice
as the mutagen and strain of choice respectively. Once
new mutants are characterized and proven heritable, they
are made available to academic researchers for the cost
of shipping only (for-profit organizations are charged an
additional $250.00 USD). Instructions for ordering are on
the Center’s website.
To date, the Center has identified over 400 phenotypic
deviants, about 100 of which have been proven heritable.
As a participant in the Mouse Phenome Project, the
Center is in the process of comprehensively characterizing
the heart, lung, blood, and sleep phenotypes of the Mouse
Phenome Project strains. This is allowing scientists to
choose the strains most appropriate to cross for identifying
QTLs associated with cardiovascular, respiratory, and related
phenotypes. HLBS and Mouse Phenome Project participants
have already characterized coagulation, heart rate, blood
pressure, electrocardiogram, plasma lipid, cardiovascular
organ weight, atherosclerosis susceptibility (pathogenaccelerated and pathogen-free), lung volume, respiratory
rate, airway hyperreactivity, and related phenotypes for some
or all Phenome strains. Data are published and publicly
accessible in the Mouse Phenome Database. Additionally,
the Center has used its strain survey data to carry out QTL
crosses for baseline peripheral blood counts, HDL levels, and
disordered sleep.

Online Resources
Cardiogenomics PGA and Website

The goal of the Cardiogenomics Program for Genomics
Application (PGA) is to characterize the genetic and
environmental factors that regulate cardiovascular function
and disease. The PGA also provides extensive training in
cardiovascular research: ongoing journal clubs and seminars,
symposia at major conferences, and workshops relevant to
cardiovascular research.
The Cardiogenomics website
(cardiogenomics.med.harvard.edu/home) publishes
high quality and comprehensive data for the genomics of
structural and functional adaptation of the cardiovascular
system. It integrates expression data from animal models
and human tissue samples, mutation screening of candidate
genes in patients, and DNA polymorphisms in awellcharacterized general population. This data set will serve as a
benchmark for future basic, clinical, and pharmacogenomic
studies.

The Jackson Laboratory
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Courses and Conferences
We host several courses that are particularly helpful
to cardiovascular researchers. Most of them are offered
yearly, are one to two weeks long, and consist of a mixture
of lectures, hands-on workshops, discussion groups, and
tutorials. Many are held in a retreat-like setting at the High
Seas facility overlooking the ocean in Bar Harbor.
To ensure a supportive learning atmosphere with exceptional
interaction between students and faculty, the courses are
generally limited to 35 participants. We recommend that
you register early. For more details on content, registration,
enrollment limits, and continuing education credits for
Jackson Laboratory courses, see the Courses and Conference
website at www.jax.org/courses.

Comprehensive Approaches to the In Vivo
Assessment of Cardiovascular Function
in Mice

This workshop focuses on assessing cardiovascular
function in mouse models. Lectures are given by leaders in
the field of cardiovascular physiology, pharmacology, and
pathology. Participants are taught to use the Visualsonics
Vevo 770 system to perform non-invasive high-resolution
ultrasound, use telemetry (DataSciences International) and
catheter-dependent (ADInstruments) approaches to monitor
cardiovascular parameters in vivo, analyze data collected
during the workshop, perform various surgeries, and
administer anesthetics.

Genomic and Proteomic Approaches to
Complex Heart, Lung, Blood, and
Sleep Disorders

Participants in this highly acclaimed, intensive, nine-day
course learn how to use statistics, molecular biology and
genetics to analyze complex diseases such as atherosclerosis,
hypertension, and asthma in humans and animal models.
They learn to detect the genetic basis of disease, perform
linkage analysis, conduct genome scans, analyze quantitative
trait loci, detect gene interactions, map complex disease
genes, clone genes, and characterize gene functions. They are
introduced to contemporary approaches of gene discovery,
such as mutagenesis and microarray analysis, are introduced
to the latest bioinformatics tools (such as OMIM, MGD,
Unigene, GeneBank, Blast, Gene-scan, SwissProt, and
Entrez), and they engage in in-depth discussions about the
social and ethical aspects of generating and using
genetic information.
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Phenotyping Mouse Models of Human
Lung Disease

This five-day workshop provides hands-on training in
phenotyping mouse mutants for cardiovascular defects, and
heart, lung, blood, and sleep disorders. The course focuses
primarily on measuring blood pressure, ultrasound, EKG
and coagulation profiles, and the theory and methods used
for screening sleep and respiratory mutants.

Annual Short Course on Medical and
Experimental Mammalian Genetics

Offered here every summer for nearly 50 years, this
two-week course features daily morning and evening
lectures and afternoon mini-symposia, workshops, tutorials,
and demonstrations. The course implicitly focuses on
translational biology and clinical applications of biomedical
research. It covers three broad areas:
1) genetics in experimental animals and humans, 2) the
relationship of heredity to disease in experimental animals
and humans, and 3) the importance of molecular genetics
in diagnosing and treating inherited disorders. Many of the
lectures, workshops, and symposia are either on or include
cardiovascular research.

Annual Workshop on the Pathology of Mouse
Models for Human Disease
This week-long workshop provides intensive training
sessions in pathology and histopathology and includes
didactic sessions on particular diseases and models.
Participants interact with prominent mouse pathologists
and geneticists from leading research institutions.

Courses and Conferences
Short Course on Systems Genetics

This seven-day course focuses on using the mouse as
a paradigm for mathematical approaches to studying
complex human diseases. The course objectives are to:
1) help geneticists and statisticians better understand
and incorporate each others’ skills in analyzing complex
phenotypes (most notably, disease); 2) help researchers
more critically evaluate the evidence of genetic and
biomolecular studies; 3) help investigators use contemporary
statistics to design molecular and genetic studies; and
4) develop professional relationships that promote
interdisciplinary research.

Methods in Human Embryonic
Stem Cell Research

This five-day workshop teaches participants state-ofthe-art techniques on how to culture, manipulate, and
differentiate embryonic stem (ES) cells from humans and
other species in vitro.

The Jackson Laboratory
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Support Services
Technical Support
Having access to our outstanding staff of research
scientists, the members of our highly skilled, informed,
and dedicated Technical Information Support team are well
equipped to answer your technical questions, help
you select mouse models, and give you information to
facilitate your research. You can call them at
1-800-422-6423, 1-207-288-5845, send an email to
micetech@jax.org, or fill out and send the email contact
form at www.jax.org/jaxmice/micetech.

Customer Service
Members of our personal, courteous, and efficient
Customer Service staff understand what it’s like to be a
customer and are particularly attuned to the needs of
research scientists. They will do everything possible to
ensure that you receive the JAX® Mice you need, in the
quantities you need, and on time. To better serve our

customers, our Customer Support Representatives accept
orders for JAX® Mice until 3:00 PM Pacific time (6:00 PM
ET). Available mice ordered by that time are packed and
shipped the next day. To order mice (if to U.S. destinations),
call 1-800-422-6423, 1-207-288-5845, or send an email
to orderquest@jax.org. To order mice from international
destinations, call 1-207-288-5845.

Regional Representatives
We serve the global biomedical research community. Our
talented, knowledgeable, and friendly team of Regional
Representatives will gladly speak with you about how our
resources and JAX® Mice and Services can facilitate your
research and make the best use of your research dollars.

Contact information for your local Regional Representative
can be found on the following website: www.jax.org/jaxmice/
services/manager. For a list of international distributors, see
www.jaxmice.jax.org/orders/international/distributors.

JAX® Mice News
Subscribe to JAX® Mice News, our email publication, and be the first to learn about new
cardiovascular research models. JAX® Mice News is also a great way to keep informed about the
latest JAX® Mice and Services, online bioinformatics resources, courses and conferences, and
research news from The Jackson Laboratory. To begin receiving this valuable resource, complete
the online subscription form at www.jax.org/jaxmice/news/quick.
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